Target intelligence / Profile preview

Cornulin (CRNN)

Target
CRNN
Molecular classification
Other (S100-fused type calcium-binding protein; fused gene family; differentiation marker)
01

Overview

Cornulin (CRNN) is a calcium-binding protein predominantly expressed in stratified squamous epithelial tissues such as the skin, esophagus, and cervix[2][4][5]. It belongs to the S100-fused type protein family and is characterized by EF-hand Ca2+ binding domains and repeat-rich C-terminal regions[3][4]. Cornulin is involved in epithelial differentiation and functions as a stress-response protein, potentially acting as a tumor suppressor in squamous cell carcinomas, where its expression is often downregulated during progression[2][5]. However, overexpression of Cornulin in some cancers has cancer-promoting effects by facilitating cell cycle progression and inhibiting apoptosis[1]. It has been shown to regulate epidermal growth, cell cycle G1/S transition (via cyclin D1), and responds to inflammatory or stress signals, with its level serving as a useful biomarker for cancer diagnosis and prognosis in squamous epithelium-derived malignancies[1][2][5]. There are no approved therapeutic drugs that directly target cornulin, and it is not currently considered a direct druggable or therapeutic target.

Other names
CornulinCRNNC1orf10DRC1PDRC1SEP5353 kDa putative calcium-binding protein53 kDa squamous epithelial-induced stress protein58 kDa heat shock proteinsquamous epithelial heat shock protein 53tumor-related protein
02

Biological functions

Cell proliferationG1/S cell cycle progressionEpidermal differentiationCalcium ion bindingResponse to pro-inflammatory cytokine signalingRegulation of apoptosisStress response in squamous epithelium
03

Disease associations

Cancer (particularly squamous cell carcinomas: esophageal, cutaneous, cervical, oropharyngeal, oral, head and neck)Eczema (to a lesser extent)
04

Interacting drugs

5-fluorouracil (used in experimental models to induce apoptosis for functional analysis)
05

Biomarkers

Diagnostic and prognostic biomarker for squamous cell carcinoma progression (expression level correlates with disease stage/progression)Marker of late epidermal differentiation

Beyond the preview

Go deeper on Cornulin (CRNN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cornulin (CRNN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call